M. Lancaster

1.9k total citations · 1 hit paper
24 papers, 1.5k citations indexed

About

M. Lancaster is a scholar working on Small Animals, Cell Biology and Plant Science. According to data from OpenAlex, M. Lancaster has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Small Animals, 5 papers in Cell Biology and 5 papers in Plant Science. Recurrent topics in M. Lancaster's work include Helminth infection and control (6 papers), Plant Pathogens and Fungal Diseases (5 papers) and Nematode management and characterization studies (3 papers). M. Lancaster is often cited by papers focused on Helminth infection and control (6 papers), Plant Pathogens and Fungal Diseases (5 papers) and Nematode management and characterization studies (3 papers). M. Lancaster collaborates with scholars based in United States, United Kingdom and Japan. M. Lancaster's co-authors include Michael A. Pfaller, John Rex, Michael G. Rinaldi, Frank C. Odds, Ana Espinel‐Ingroff, Mahmoud A. Ghannoum, J N Galgiani, Marilyn S. Bartlett, Thomas J. Walsh and A L Barry and has published in prestigious journals such as Clinical Infectious Diseases, International Journal of Molecular Sciences and Journal of Clinical Microbiology.

In The Last Decade

M. Lancaster

24 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

1997 719 citations John Rex, Michael A. Pfaller et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Lancaster United States	14	1.1k	718	262	226	183	24	1.5k
Anne Bolmström United States	19	937 0.8×	579 0.8×	430 1.6×	341 1.5×	84 0.5×	25	1.4k
M G Rinaldi United States	22	1.7k 1.5×	1.4k 1.9×	75 0.3×	268 1.2×	191 1.0×	29	2.3k
Christine J. Morrison United States	26	1.7k 1.5×	1.4k 1.9×	134 0.5×	414 1.8×	140 0.8×	43	2.6k
Adrien Székely United Kingdom	24	1.4k 1.2×	1.1k 1.5×	94 0.4×	260 1.2×	134 0.7×	30	1.8k
V. A. Newell United States	8	1.4k 1.2×	1.1k 1.6×	73 0.3×	184 0.8×	73 0.4×	8	1.6k
Bansidhar Tarai India	18	1.5k 1.3×	1.1k 1.5×	86 0.3×	196 0.9×	90 0.5×	62	1.9k
Joaquín V. Martínez‐Suárez Spain	30	1.0k 0.9×	893 1.2×	72 0.3×	414 1.8×	185 1.0×	65	2.3k
J. L. Rodriguez-Tudela Spain	18	1.2k 1.1×	942 1.3×	76 0.3×	184 0.8×	216 1.2×	24	1.7k
Kizee A. Etienne United States	14	1.5k 1.3×	1.2k 1.6×	66 0.3×	224 1.0×	95 0.5×	21	1.8k
Anupam Prakash India	16	2.0k 1.7×	1.7k 2.4×	120 0.5×	190 0.8×	77 0.4×	29	2.2k

Countries citing papers authored by M. Lancaster

Since Specialization

Citations

This map shows the geographic impact of M. Lancaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lancaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lancaster more than expected).

Fields of papers citing papers by M. Lancaster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Lancaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lancaster. The network helps show where M. Lancaster may publish in the future.

Co-authorship network of co-authors of M. Lancaster

This figure shows the co-authorship network connecting the top 25 collaborators of M. Lancaster. A scholar is included among the top collaborators of M. Lancaster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Lancaster. M. Lancaster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lancaster, M., Paul S. Hafen, Andrew Law, et al.. (2024). Sucla2 Knock‐Out in Skeletal Muscle Yields Mouse Model of Mitochondrial Myopathy With Muscle Type–Specific Phenotypes. Journal of Cachexia Sarcopenia and Muscle. 15(6). 2729–2742. 1 indexed citations

Lancaster, M. & Brett H. Graham. (2023). Succinyl-CoA Synthetase Dysfunction as a Mechanism of Mitochondrial Encephalomyopathy: More than Just an Oxidative Energy Deficit. International Journal of Molecular Sciences. 24(13). 10725–10725. 15 indexed citations

Lancaster, M., Byung-Wook Kim, Emma H. Doud, et al.. (2023). Loss of succinyl-CoA synthetase in mouse forebrain results in hypersuccinylation with perturbed neuronal transcription and metabolism. Cell Reports. 42(10). 113241–113241. 13 indexed citations

Tenover, Fred C., et al.. (1998). Characterization of Staphylococci with Reduced Susceptibilities to Vancomycin and Other Glycopeptides. Journal of Clinical Microbiology. 36(4). 1020–1027. 301 indexed citations

Rex, John, Michael A. Pfaller, J N Galgiani, et al.. (1997). Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections. Clinical Infectious Diseases. 24(2). 235–247. 719 indexed citations breakdown →

Lozano‐Chiu, Mario, et al.. (1997). Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin B. Journal of Clinical Microbiology. 35(1). 270–272. 42 indexed citations

Pfaller, Michael A., Martha J. Bale, Barry J. Buschelman, et al.. (1995). Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine. Journal of Clinical Microbiology. 33(5). 1104–1107. 114 indexed citations

Pfaller, Michael A., M. Lancaster, Ana Espinel‐Ingroff, et al.. (1994). Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. Journal of Clinical Microbiology. 32(7). 1625–1628. 56 indexed citations

Pfaller, Michael A., Martha J. Bale, Barry J. Buschelman, et al.. (1994). Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods. Journal of Clinical Microbiology. 32(7). 1650–1653. 53 indexed citations

10.

Lancaster, M. & C. Hong. (1987). Observations on the pattern of nematode larval availability on pasture grazed annually by cattle, 1959 to 1985. Veterinary Record. 120(21). 502–503. 10 indexed citations

11.

Lancaster, M. & C. Hong. (1987). Differentiation of third stage larvae of 'ovine Ostertagia' type and Trichostrongylus species. Veterinary Record. 120(21). 503–503. 15 indexed citations

12.

Lancaster, M., et al.. (1981). Worm burdens of dairy heifers in England and Wales. Veterinary Record. 109(1). 12–14. 11 indexed citations

13.

Lancaster, M., et al.. (1981). Further observations on the action of fenbendazole against inhibited fourth stage larvae of Ostertagia ostertagi. Veterinary Record. 108(22). 473–475. 4 indexed citations

14.

Mykkänen, Hannu, J.W.T. Dickerson, & M. Lancaster. (1980). Strain differences in lead intoxication in rats. Toxicology and Applied Pharmacology. 52(3). 414–421. 10 indexed citations

15.

Lancaster, M., et al.. (1979). Effects of deferoxamine methanesulfonate on Trichophyton mentagrophytes.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 17(3). 241–50. 3 indexed citations

16.

Lancaster, M., et al.. (1978). Plasma pepsinogen levels in some experimental infections of Ostertagia ostertagi in cattle. Veterinary Record. 103(17). 370–373. 15 indexed citations

17.

Lancaster, M.. (1977). Action of fenbendazole on arrested fourth stage larvae of Ostertagia ostertagi. Veterinary Record. 101(4). 81–82. 23 indexed citations

18.

Lancaster, M., et al.. (1976). USAFSAM ECG/VCG Digitizing and Averaging System.. Defense Technical Information Center (DTIC). 2 indexed citations

19.

Lancaster, M.. (1973). The occurrence of Streptocara sp. in ducks in Britain. Veterinary Record. 92(10). 261–262. 5 indexed citations

20.

Cavanagh, John, et al.. (1961). COMPARISON OF THE FUNCTIONAL EFFECTS OF DYFLOS, TRI‐O‐CRESYL PHOSPHATE AND TRI‐p‐ETHYLPHENYL PHOSPHATE IN CHICKENS. British Journal of Pharmacology and Chemotherapy. 17(1). 21–27. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact